Ferroptosis as an emerging target in sickle cell disease

Sickle cell disease (SCD) is an inherited hemoglobin disorder marked by red blood cell sickling, resulting in severe anemia, painful episodes, extensive organ damage, and shortened life expectancy. In SCD, increased iron levels can trigger ferroptosis, a specific type of cell death characterized by...

Full description

Saved in:
Bibliographic Details
Main Authors: Vitor Fortuna, Jaqueline Lima, Gabriel F. Oliveira, Yasmin S. Oliveira, Bruk Getachew, Sergei Nekhai, Michael Aschner, Yousef Tizabi
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Current Research in Toxicology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666027X24000343
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110592284622848
author Vitor Fortuna
Jaqueline Lima
Gabriel F. Oliveira
Yasmin S. Oliveira
Bruk Getachew
Sergei Nekhai
Michael Aschner
Yousef Tizabi
author_facet Vitor Fortuna
Jaqueline Lima
Gabriel F. Oliveira
Yasmin S. Oliveira
Bruk Getachew
Sergei Nekhai
Michael Aschner
Yousef Tizabi
author_sort Vitor Fortuna
collection DOAJ
description Sickle cell disease (SCD) is an inherited hemoglobin disorder marked by red blood cell sickling, resulting in severe anemia, painful episodes, extensive organ damage, and shortened life expectancy. In SCD, increased iron levels can trigger ferroptosis, a specific type of cell death characterized by reactive oxygen species (ROS) and lipid peroxide accumulation, leading to damage and organ impairments. The intricate interplay between iron, ferroptosis, inflammation, and oxidative stress in SCD underscores the necessity of thoroughly understanding these processes for the development of innovative therapeutic strategies. This review highlights the importance of balancing the complex interactions among various factors and exploitation of the knowledge in developing novel therapeutics for this devastating disease.
format Article
id doaj-art-94b5b2894d3345ffbb48fdaddd17a9fb
institution OA Journals
issn 2666-027X
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series Current Research in Toxicology
spelling doaj-art-94b5b2894d3345ffbb48fdaddd17a9fb2025-08-20T02:37:48ZengElsevierCurrent Research in Toxicology2666-027X2024-01-01710018110.1016/j.crtox.2024.100181Ferroptosis as an emerging target in sickle cell diseaseVitor Fortuna0Jaqueline Lima1Gabriel F. Oliveira2Yasmin S. Oliveira3Bruk Getachew4Sergei Nekhai5Michael Aschner6Yousef Tizabi7Department of Biochemistry and Biophysics, Health Sciences Institute, Federal University of Bahia, BA 40231-300, Brazil; Postgraduate Program in Immunology, Health Sciences Institute, Federal University of Bahia, BA 40231-300, BrazilPostgraduate Program in Immunology, Health Sciences Institute, Federal University of Bahia, BA 40231-300, BrazilPostgraduate Program in Immunology, Health Sciences Institute, Federal University of Bahia, BA 40231-300, BrazilPostgraduate Program in Immunology, Health Sciences Institute, Federal University of Bahia, BA 40231-300, BrazilDepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USACenter for Sickle Cell Disease, Departments of Microbiology and Medicine, Howard University College of Medicine, Washington, DC, USADepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USADepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USA; Corresponding author at: Department of Pharmacology, Howard University College of Medicine, 520 W Street NW, Washington, DC, 20059, USA.Sickle cell disease (SCD) is an inherited hemoglobin disorder marked by red blood cell sickling, resulting in severe anemia, painful episodes, extensive organ damage, and shortened life expectancy. In SCD, increased iron levels can trigger ferroptosis, a specific type of cell death characterized by reactive oxygen species (ROS) and lipid peroxide accumulation, leading to damage and organ impairments. The intricate interplay between iron, ferroptosis, inflammation, and oxidative stress in SCD underscores the necessity of thoroughly understanding these processes for the development of innovative therapeutic strategies. This review highlights the importance of balancing the complex interactions among various factors and exploitation of the knowledge in developing novel therapeutics for this devastating disease.http://www.sciencedirect.com/science/article/pii/S2666027X24000343Sickle cell diseaseIron toxicityFerroptosisOxidative stressLipid peroxidationNovel targets
spellingShingle Vitor Fortuna
Jaqueline Lima
Gabriel F. Oliveira
Yasmin S. Oliveira
Bruk Getachew
Sergei Nekhai
Michael Aschner
Yousef Tizabi
Ferroptosis as an emerging target in sickle cell disease
Current Research in Toxicology
Sickle cell disease
Iron toxicity
Ferroptosis
Oxidative stress
Lipid peroxidation
Novel targets
title Ferroptosis as an emerging target in sickle cell disease
title_full Ferroptosis as an emerging target in sickle cell disease
title_fullStr Ferroptosis as an emerging target in sickle cell disease
title_full_unstemmed Ferroptosis as an emerging target in sickle cell disease
title_short Ferroptosis as an emerging target in sickle cell disease
title_sort ferroptosis as an emerging target in sickle cell disease
topic Sickle cell disease
Iron toxicity
Ferroptosis
Oxidative stress
Lipid peroxidation
Novel targets
url http://www.sciencedirect.com/science/article/pii/S2666027X24000343
work_keys_str_mv AT vitorfortuna ferroptosisasanemergingtargetinsicklecelldisease
AT jaquelinelima ferroptosisasanemergingtargetinsicklecelldisease
AT gabrielfoliveira ferroptosisasanemergingtargetinsicklecelldisease
AT yasminsoliveira ferroptosisasanemergingtargetinsicklecelldisease
AT brukgetachew ferroptosisasanemergingtargetinsicklecelldisease
AT sergeinekhai ferroptosisasanemergingtargetinsicklecelldisease
AT michaelaschner ferroptosisasanemergingtargetinsicklecelldisease
AT youseftizabi ferroptosisasanemergingtargetinsicklecelldisease